By Kirsten Grind
Effort involves BlackRock, J.P. Morgan, BNY Mellon and others
Big money managers led by Fidelity Investments are close to launching a private trading venue designed to let them buy and sell large blocks of stock without the involvement of Wall Street firms and high-speed traders, according to people familiar with the matter.

Riverbed Technology (NASDAQ:RVBD), the leader in application performance
infrastructure, is pleased to announce that the winner of the 2014
Riverbed ® SteelScript ™ Ideas Contest is Lionel
Marie, network architect at Schneider Electric, a 176-year-old French
firm that specializes in energy management.

Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced dosing of the first patient in a new clinical trial
evaluating the combination of VS-5584, its dual mTORC1/2 and PI3K
inhibitor, in combination with VS-6063, the Company’s lead focal
adhesion kinase (FAK) inhibitor, in patients with relapsed mesothelioma.

Halliburton Company (NYSE:HAL) announced today that income from
continuing operations for the fourth quarter of 2014 was $1.0 billion,
or $1.19 per diluted share, excluding restructuring charges of $90
million, after-tax, or $0.11 per diluted share, and Baker Hughes
acquisition-related costs of $19 million, after-tax, or $0.02 per
diluted share.

Royal Gold, Inc. (NASDAQ:RGLD; TSX:RGL) (together with its
subsidiaries, “Royal Gold” or the “Company”) announces that the
operators of the Mount Milligan and Peñasquito properties have released
preliminary calendar 2014 operating results and calendar 2015 production
forecasts.

Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that
information, presented last week in San Francisco, introducing its
pivotal scleroderma trial (“the STAR trial”), is now available on the
company website at www.Cytori.com .